| Diagnosis and Treatment of Ovarian Cancer |
24 |
| Molecular Basis and Genetic Modifiers of Thalassemia |
17 |
| Cutaneous Squamous Cell Carcinoma |
16 |
| Pathology of Castleman Disease |
14 |
| Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer |
13 |
| Management and Treatment of Recurrent Epithelial Ovarian Cancer |
13 |
| Early Detection of Ovarian Cancer |
12 |
| Treatment of Idiopathic Castleman Disease |
11 |
| Cutaneous Melanoma-A Review in Detection, Staging, and Management |
11 |
| Castleman Disease Pathogenesis |
11 |
| Cancer Vaccines |
11 |
| Germline GATA2 Mutation and Bone Marrow Failure |
10 |
| Diagnosis of Castleman Disease |
10 |
| TAFRO Syndrome |
9 |
| The Role of Interleukin-6 in Castleman Disease |
9 |
| Epidemiology of Castleman Disease |
9 |
| Cancer Pain Syndromes |
9 |
| Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer |
8 |
| Genomic Landscape of Waldenstrom Macroglobulinemia |
8 |
| The Pathophysiology of Acquired Aplastic Anemia Current Concepts Revisited |
8 |
| Clinical Classification, Screening and Diagnosis for Thalassemia |
8 |
| Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia |
8 |
| Unicentric Castleman Disease |
8 |
| Mycosis Fungoides and Sezary Syndrome: An Update |
7 |
| Basal Cell Carcinoma Review |
7 |
| Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease |
7 |
| Key Components of Pain Management for Children and Adults with Sickle Cell Disease |
7 |
| The Evolving Spectrum of the Epidemiology of Thalassemia |
7 |
| Ineffective Erythropoiesis: Anemia and Iron Overload |
7 |
| Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome |
7 |
| Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita |
7 |
| Spiritual Considerations |
6 |
| Immunotherapy for Head and Neck Cancer |
6 |
| Vascular Anomalies Diagnosis of Complicated Anomalies and New Medical Treatment Options |
6 |
| Extramammary Paget's Disease |
6 |
| Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma |
5 |
| Malignant Sweat Gland Tumors |
5 |
| Safe Opioid Use Management of Opioid-Related Adverse Effects and Aberrant Behaviors |
5 |
| Somatic Mutations in Aplastic Anemia |
5 |
| Disorders of Iron Metabolism New Diagnostic and Treatment Approaches to Iron Deficiency |
5 |
| Inherited Platelet Disorders A Modern Approach to Evaluation and Treatment |
5 |
| Risk Factors for Ovarian Carcinoma |
5 |
| Targeting Angiogenesis Taming the Medusa of Ovarian Cancer |
5 |
| Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer |
4 |
| Immunotherapy Toxicity |
4 |
| Cancer-Related Neuropathic Pain: Review and Selective Topics |
4 |
| Oncology Acupuncture for Chronic Pain in Cancer Survivors: A Reflection on the American Society of Clinical Oncology Chronic Pain Guideline |
4 |
| Pain Syndromes and Management in Adult Hematopoietic Stem Cell Transplantation |
4 |
| Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia |
4 |
| Beta Thalassemia Monitoring and New Treatment Approaches |
4 |
